tranexamic acid has been researched along with Myocardial Ischemia in 2 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
van Caster, P | 1 |
Eiling, S | 1 |
Boekholt, Y | 1 |
Behmenburg, F | 1 |
Dorsch, M | 1 |
Heinen, A | 1 |
Hollmann, MW | 1 |
Huhn, R | 1 |
Vanek, T | 1 |
Jares, M | 1 |
Fajt, R | 1 |
Straka, Z | 1 |
Jirasek, K | 1 |
Kolesar, M | 1 |
Brucek, P | 1 |
Maly, M | 1 |
1 trial available for tranexamic acid and Myocardial Ischemia
Article | Year |
---|---|
Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).
Topics: Aged; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Coronary Artery Bypass, Off-Pump; Cr | 2005 |
1 other study available for tranexamic acid and Myocardial Ischemia
Article | Year |
---|---|
Tranexamic Acid Does Not Influence Cardioprotection by Ischemic Preconditioning and Remote Ischemic Preconditioning.
Topics: Animals; Antifibrinolytic Agents; Ischemic Preconditioning, Myocardial; Male; Myocardial Ischemia; R | 2018 |